Health & Medical · Week of Nov 2, 2026
Earnings season and a planned CVS Health split: the week in health
Third-quarter results from cannabis, diagnostics, REIT and digital health firms, plus a planned CVS Health split and a Florida hospital closure.
Earnings dominated the week. Caris Life Sciences reported third-quarter revenue up 27% to $275.4 million and raised its full-year guidance to $1.04 to $1.05 billion, while GRAIL reported Galleri test volume up about 24% and a net loss of $103.6 million as it awaits an FDA decision expected by early Q1 2027. Trulieve returned to a $1 million profit on revenue down 20%, and Syra Health and Community Healthcare Trust also reported year-over-year gains in net income.
The largest structural news came from CVS Health, which says it intends to separate into two publicly traded companies, with completion expected in the first half of 2028. Elsewhere, DarioHealth named John R. Palumbo chairman, and Encompass Health said flooding has closed its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, indefinitely while reaffirming full-year guidance.
Trulieve Cannabis Corp.
Trulieve Reports Third Quarter 2026 Results
Trulieve reported third quarter 2026 revenue of $230 million, down 20% from $288 million, and net income attributable to common shareholders of $1 million versus a $27 million loss a year earlier. The company says it received final DEA registrations for state licensed medical marijuana dispensaries and repaid $65 million of mortgage notes ahead of their 2028 maturity.
Caris Life Sciences
Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance
Caris Life Sciences reported third-quarter revenue of $275.4 million, up 27%, on about 61,500 clinical cases, with net income of $15.3 million compared with $24.3 million a year earlier. It raised full-year 2026 revenue guidance to $1.04 to $1.05 billion and reported free cash flow of $(39.7) million for the quarter.
GRAIL, Inc.
GRAIL Reports Third Quarter 2026 Financial Results
GRAIL reported third quarter total revenue of $37.5 million, Galleri test revenue of $37.3 million and a net loss of $103.6 million, with more than 56,000 tests in the quarter. An FDA advisory panel voted in favor of approving Galleri in September, and the company anticipates an FDA decision by early Q1 2027.
Community Healthcare Trust Incorporated
Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026
Community Healthcare Trust reported net income of about $3.1 million, or $0.09 per diluted share, and FFO of $0.54 per diluted share, and declared an unchanged quarterly dividend of $0.33 payable November 25, 2026. The company has completed $32.3 million in property dispositions since the second quarter closed and has four properties under purchase agreements totaling about $99.0 million.
Syra Health
Syra Health Delivers Third Consecutive Profitable Quarter: Record Revenue of $2.6 Million, Up 52%, and 46.3% Gross Margin
Syra Health reported third-quarter revenue of $2,557,295, up 52%, and net income of $344,610, which the company calls its third consecutive profitable quarter. Following CMS approval of Syrenity for the ACCESS Model, the company says it is recruiting Accountable Care Organizations with partner HealthSync.
CVS Health
CVS Health Announces Intent to Create Two Distinct Leaders in Healthcare
CVS Health says it intends to split into two public companies: one holding Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health under David Joyner, and CVS Pharmacy, with about 9,000 stores and MinuteClinic, under Prem Shah. Completion is expected in the first half of 2028, subject to conditions including final board approval and confirmation of tax-free treatment.
DarioHealth Corp.
Dario Names Veteran Healthcare Executive John R. Palumbo Chairman of the Board as Company Positions Itself to Lead the Convergence of Consumer and Payer-Funded Care
DarioHealth appointed board member John R. Palumbo as Chairman effective November 3, 2026, succeeding Yoav Shaked, who remains a director. The company says more than 80% of its contracted and late-stage annual recurring revenue is multi-condition and Mr. Palumbo will join its November 12, 2026 earnings call.
Encompass Health Corp.
Encompass Health announces indefinite closure of Sea Pines Rehabilitation Hospital due to flood damage
Encompass Health said its 90-bed Sea Pines Rehabilitation Hospital in Melbourne, Florida, is closed indefinitely after Nov. 1-2, 2026 flooding, with all patients evacuated and employees accounted for. The company reaffirmed full-year 2026 guidance, noting Sea Pines generated about $44 million in net operating revenue in the first nine months of 2026.
This roundup is written with AI assistance from the press releases listed above, using only what they state. The releases are the companies' own announcements, not BlessFeed reporting.